Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and precision medicine, today announced that new data from the ...

THE WOODLANDS, Texas--(BUSINESS WIRE)--To address a gap in knowledge surrounding clinical trial participation impacts on unplanned healthcare utilization and hospice enrollment in adults with cancer, ...

Despite being more likely to be diagnosed with triple negative breast cancer (TNBC), Black women remain underrepresented in clinical trials across the U.S. While distance from trial sites may not be a ...

ALX Oncology Holdings Inc. announced that the updated results from its Phase 2 ASPEN-06 clinical trial have been accepted for oral presentation at the 2025 American Society of Clinical Oncology ...

AI innovations, such as the ASCO Guidelines Assistant, enhance evidence-based decision-making by providing quick access to critical guidelines. ASCO 2025 highlighted breakthroughs, including improved ...

Pasithea Therapeutics Corp. has announced the acceptance of an abstract for a poster presentation at the upcoming American Society for Clinical Oncology (ASCO) Annual Meeting, scheduled for May 30 to ...

LARKSPUR, Calif.--(BUSINESS WIRE)--Aulos Bioscience, an immuno-oncology company working to revolutionize cancer care through the development of potentially best-in-class IL-2 therapeutics, today ...

Unification of Efforts to Improve Global Access to Cancer Therapeutics: Report From the 2022/2023 Access to Essential Cancer Medicines Stakeholder Summit ASCO is a global professional society ...

Circle Pharma to Present Trials in Progress Poster on CID-078, a First-in-Class Cyclin A/B Inhibitor, at the ASCO 2025 Annual Meeting Circle Pharma, a clinical-stage biopharmaceutical company ...

When considering a sequence of therapy for a patient with metastatic breast cancer, oncologists rely heavily on clinical trial data. Sometimes, however, clinical trial data may not be as reliable as ...

Collaboration among trial sponsors can pool expertise and resources, potentially accelerating drug development and regulatory success. This study assessed whether collaborations between drug sponsors ...